Eric C. Peterson
Professor
Also affiliated: Dartmouth College (2021); University of Minnesota (1981); The Royal Melbourne Hospital (2018); Johns Hopkins University (2018); University of Miami (2011–2024); The University of Melbourne (2018); University of California, Irvine (1994–1999); Durham Technical Community College (2016); Johns Hopkins Medicine (2018); HCA Healthcare (2017); Harborview Medical Center (2014); Boca Raton Regional Hospital (2018–2019); Jackson Memorial Hospital (2014–2023); Henry Ford Hospital (2008); Peterson (Norway) (2018–2024); Zimmer Biomet (United States) (1998); University of Miami Hospital (2016–2017); Duke Medical Center (1998–2004); University of Pittsburgh Medical Center (2017–2018); Miami Children's Hospital (2016); Health and Education Research Management and Epidemiologic Services (United States) (2023); Duke University Hospital (1998); Neurological Surgery (2009–2023); Toronto Metropolitan University (2021); Columbia University (2016); Tokushima University (2021)
Faculty Researcher
Pharmacology & Toxicology, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Eric C. Peterson's research focuses on neurological disorders and treatments, with a particular emphasis on stroke and cerebrovascular diseases. He has published extensively on the outcomes of endovascular treatments for emergent large vessel occlusion, including mechanical thrombectomy and embolization techniques. His work also investigates the underlying mechanisms of these conditions, such as the role of netosis and inflammasomes in large vessel occlusion thrombi, and the differential expression of inflammatory and angiogenic factors in stroke patients.
Peterson also has research interests in other areas of medicine, including liver injury and dural arteriovenous fistulas. He has received funding from the NIH/National Cancer Institute as a Co-PI for the Cancer and Developing Entrepreneurial Technologies (CADET) project. His scholarship metrics include an h-index of 38, with over 5,200 citations across 155 publications, indicating a significant research impact. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Erich A. Peterson, Donald J. Johann, Ikjae Shin, and Matthew A. Steliga.
Metrics
- h-index: 38
- Publications: 155
- Citations: 5,335
Selected Publications
-
Case 3: An Uncommon Cause of Respiratory Distress in a Term Newborn (2025)
-
A functional surface display system in Saccharomyces boulardii for protein absorption in simulated intestinal fluids (2025)
-
Antagonizing the SAMD9 pathway is key to myxoma virus host shut-off and immune evasion (2024)
-
Liquid biopsy based on circulating tumor DNA for lung cancer: A step toward prevention (2023)
-
An advanced molecular medicine case report of a rare human tumor using genomics, pathomics, and radiomics (2023)
-
Effect of Antigen Retrieval on Genomic DNA From Immunodissected Samples (2022)
-
Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human monocytes/macrophages (2022)
-
Abstract 5038: Applying reproducible genomic data science methods for the analysis of a rare tumor type (2022)
-
Microdissection Methods Utilizing Single-Cell Subtype Analysis and the Impact on Precision Medicine (2022)
-
Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human macrophages (2022)
-
NPARS—A Novel Approach to Address Accuracy and Reproducibility in Genomic Data Science (2021)
-
Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed (2021)
-
Exogenous phosphatidic acid reduces acetaminophen-induced liver injury in mice by activating hepatic interleukin-6 signaling through inter-organ crosstalk (2021)
-
Synergizing microdissection with ddPCR to advance precision oncology. (2021)
Federal Grants 1 $270,624 total
Grants & Funding
As listed on this researcher's institutional profile. Federal awards with verified records are shown above.
- Active Immunization for Treating Methamphetamine Abuse NIH/Nat. Inst. on Drug Abuse Co-Investigator
- Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse NIH/Nat. Inst. on Drug Abuse Co-Investigator
- Antibody-based Therapy for Methamphetamine Abuse NIH/Nat. Inst. on Drug Abuse Co-Investigator
- Technology for Identification of Epiproteomes in Tissue Samples NIH Co-Investigator
- Single Chain Antibody Medications for(+)METH Abuse NIH Principal Investigator
- Antibody Gene Therapy for Methamphetamine Abuse NIH Principal Investigator
- Antibody-nanoparticle conjugates for the treatment of methamphetamine abuse NIH Principal Investigator
- Arkansas Collaborative for Technological and Innovative Venture Equality (ACTIVE) US Department of Commerce Principal Investigator
Collaboration Network
Top Collaborators
- A functional surface display system in Saccharomyces boulardii for protein absorption in simulated intestinal fluids
- A functional surface display system in Saccharomyces boulardii for protein absorption in simulated intestinal fluids
- A functional surface display system in Saccharomyces boulardii for protein absorption in simulated intestinal fluids
- A functional surface display system in Saccharomyces boulardii for protein absorption in simulated intestinal fluids
- A functional surface display system in Saccharomyces boulardii for protein absorption in simulated intestinal fluids
- Case 3: An Uncommon Cause of Respiratory Distress in a Term Newborn
- Case 3: An Uncommon Cause of Respiratory Distress in a Term Newborn
- Case 3: An Uncommon Cause of Respiratory Distress in a Term Newborn
Similar Researchers
Based on overlapping research topics